Nutritional Growth Solutions Issues 51,302 Shares at $0.018 to Extinguish Non-Related Party Loan

Manish Choudhary

09 November 2026 03:33 PM AEDT

Nutritional Growth Solutions Issues 51,302 Shares at $0.018 to Extinguish Non-Related Party Loan

Image Source: Krish Capital Pty Ltd

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Nutritional Growth Solutions (ASX:NGS) has issued 51,302 fully paid ordinary shares at a deemed issue price of $0.018 per share to extinguish a loan owed to a non-related party in lieu of cash repayment, according to a filing dated 9 November 2026.

Key Points

51,302 fully paid ordinary shares were issued on 9 November 2026 at a deemed issue price of $0.018 per share.
The shares were issued to a non-related party to extinguish an existing loan in lieu of cash repayment.
The shares were issued without disclosure to the non-related party under Part 6D.2 of the Corporations Act 2001 (Cth).
The notice was given by Company Secretary Adam Gallagher on behalf of the Board of Directors.

Share Issuance Details

Nutritional Growth Solutions Limited issued 51,302 fully paid ordinary shares on 9 November 2026 at a deemed issue price of $0.018 per share. The shares were issued to a non-related party for the purpose of extinguishing a loan held by that party, with the issuance serving as repayment in lieu of cash. The filing states the shares were issued without disclosure to the non-related party under Part 6D.2 of the Corporations Act 2001 (Cth). The notice was submitted under section 708A(5)(e) of the Corporations Act 2001 (Cth).

Section 708A Corporations Act Compliance Disclosure

In accordance with sections 708A(5)(e) and 708A(6) of the Corporations Act 2001 (Cth), the company disclosed that as at the date of the notice, it had complied with the provisions of Chapter 2M of the Act as they apply to the company, as well as sections 674 and 674A of the Act. The company also confirmed that as at the date of the notice, there is no information that constitutes "excluded information" within the meaning of sections 708A(7) and 708A(8) of the Act that is required to be disclosed under section 708A(6)(e) of the Act.

Company Secretary Authorisation

The filing was authorised and lodged by Adam Gallagher, Company Secretary of Nutritional Growth Solutions Limited, on behalf of the Board of Directors. The company is registered with the Australian Registrar of Business Names under ARBN 642 861 774 and is listed on the Australian Securities Exchange under the ticker NGS. The company's registered office is located at Suite 301, 2 Nexus Court, Mulgrave VIC 3170, as stated in the filing.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.